Anpario (LON:ANP) Issues Quarterly Earnings Results

Anpario (LON:ANP) announced its earnings results on Wednesday. The company reported GBX 22.45 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Anpario had a net margin of 14.31% and a return on equity of 16.88%.

Anpario Price Performance

Shares of Anpario stock traded down GBX 13.50 during trading hours on Thursday, reaching GBX 466.50. 73,137 shares of the company’s stock were exchanged, compared to its average volume of 45,578. Anpario has a 1 year low of GBX 391.11 and a 1 year high of GBX 580. The company has a market capitalization of £75.97 million, a P/E ratio of 12.30 and a beta of 1.08. The business has a fifty day moving average of GBX 531.50 and a two-hundred day moving average of GBX 516.75. The company has a quick ratio of 5.16, a current ratio of 4.50 and a debt-to-equity ratio of 0.60.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on ANP. Canaccord Genuity Group restated a “buy” rating and set a GBX 570 price target on shares of Anpario in a research report on Friday, June 26th. Shore Capital Group reiterated a “house stock” rating on shares of Anpario in a report on Monday, August 17th. One analyst has rated the stock with a Buy rating, According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of GBX 570.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.